Mesterolone

Proviron Capsule

膠囊劑TaiwanCancelledAuthorised 28 Feb 1975

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Mesterolone

Proviron Capsule

膠囊劑TaiwanCancelledAuthorised 28 Feb 1975

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Taiwan Food and Drug Administration

TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates

Licence: Taiwan Government Open Data Licence 1.0 · Added 7 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Mesterolone
Dosage form: 膠囊劑
Register: Taiwan (TFDA)
Status: Cancelled
Status in the register: 已註銷
Authorised: 28 Feb 1975
Registration: 衛署藥製字第005952號
Marketing authorisation holder: 臺灣先靈股份有限公司
Procedure: 製　劑